Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2024

Investments, All Other Investments [Abstract]

Schedule of Cash and Cash Equivalents, Restricted Cash and Investments

The following table summarizes the Company’s cash and cash equivalents, amortized cost, gross unrealized gains, gross unrealized losses, and fair value by significant category reported as cash and cash equivalents and restricted cash as of December 31, 2024 and 2023:

	December 31, 2024
	Reported as:
(in thousands)	Cash and Cash Equivalents		Restricted Cash- current		Short-term Investments		Restricted Cash
Cash	$	969	$	-	$	-	$	-
Level 2
Money market funds		11,248		219		-		-
Subtotal		11,248		219		-		-
Total assets measured at fair value	$	12,217	$	219	$	-	$	-

	December 31, 2023
	Reported as:
(in thousands)	Cash and Cash Equivalents		Restricted Cash- current		Short-term Investments		Restricted Cash
Cash	$	2,122	$	-	$	-	$	-
Level 2
Money market funds		17,696		525		-		219
Subtotal		17,696		525		-		219
Total assets measured at fair value	$	19,818	$	525	$	-	$	219